Cholestasis of pregnancy: Clinical sciences

Last updated: January 30, 2025

Cholestasis of pregnancy: Clinical sciences

Pregnancy, childbirth, and the puerperium

Pregnancy, childbirth, and the puerperium

Preconception care: Clinical sciences
Antepartum fetal surveillance: Clinical sciences
Fetal aneuploidy screening: Clinical sciences
Maternal D alloimmunization (prevention): Clinical sciences
Antepartum care (first trimester): Clinical sciences
Antepartum care (second trimester): Clinical sciences
Antepartum care (third trimester): Clinical sciences
Cytomegalovirus (CMV), parvovirus B19, varicella zoster, and toxoplasmosis infection in pregnancy: Clinical sciences
Group B streptococcus (GBS) colonization in pregnancy: Clinical sciences
Herpes simplex virus infection in pregnancy: Clinical sciences
Abdominal trauma in pregnancy: Clinical sciences
Anemia in pregnancy: Clinical sciences
Approach to acute pelvic pain (GYN): Clinical sciences
Approach to diabetes in pregnancy: Clinical sciences
Approach to first trimester bleeding: Clinical sciences
Approach to hypertensive disorders in pregnancy: Clinical sciences
Approach to third trimester bleeding: Clinical sciences
Cholestasis of pregnancy: Clinical sciences
Diabetes in pregnancy (GDM, T1DM, and T2DM): Clinical sciences
Early pregnancy loss: Clinical sciences
Ectopic pregnancy: Clinical sciences
Fetal growth restriction: Clinical sciences
Gestational hypertension, preeclampsia, eclampsia, and HELLP: Clinical sciences
Hemoglobinopathies in pregnancy: Clinical sciences
Intraamniotic infection: Clinical sciences
Maternal D alloimmunization (management): Clinical sciences
Multifetal gestation: Clinical sciences
Nausea and vomiting of pregnancy: Clinical sciences
Placenta accreta spectrum: Clinical sciences
Placenta previa and vasa previa: Clinical sciences
Placental abruption: Clinical sciences
Therapeutic and induced abortions: Clinical sciences
Induction of labor: Clinical sciences
Intrapartum care (1st, 2nd, 3rd, and 4th stages): Clinical sciences
Intrapartum fetal heart rate monitoring: Clinical sciences
Late-term and postterm pregnancy: Clinical sciences
Pain management during labor: Clinical sciences
Prelabor rupture of membranes: Clinical sciences
Preterm labor: Clinical sciences
Protraction and arrest disorders: Clinical sciences
Shoulder dystocia: Clinical sciences
Vaginal birth after cesarean (VBAC): Clinical sciences
Approach to postpartum fever: Clinical sciences
Approach to postpartum hemorrhage: Clinical sciences
Perinatal depression and anxiety: Clinical sciences
Uterine atony: Clinical sciences
Immediate care of the well newborn: Clinical sciences
Approach to a rash in the well newborn and infant: Clinical sciences
Approach to anemia in the newborn and infant (destruction and blood loss): Clinical sciences
Approach to anemia in the newborn and infant (underproduction): Clinical sciences
Approach to birth injury (pediatrics): Clinical sciences
Approach to complications of prematurity (early): Clinical sciences
Approach to complications of prematurity (late): Clinical sciences
Approach to congenital infections: Clinical sciences
Approach to cyanosis (newborn): Clinical sciences
Approach to hypotonia (newborn and infant): Clinical sciences
Approach to jaundice (newborn and infant): Clinical sciences
Approach to respiratory distress (newborn): Clinical sciences
Approach to vomiting (newborn and infant): Clinical sciences
Neonatal respiratory distress syndrome: Clinical sciences
Alcohol, tobacco, cannabinoid, and substance use in pregnancy: Clinical sciences
Approach to prenatal teratogen exposure: Clinical sciences
Asthma in pregnancy: Clinical sciences
Chronic hypertension in pregnancy: Clinical sciences
Urinary tract infections and kidney stones in pregnancy: Clinical sciences
Venous thromboembolism in pregnancy: Clinical sciences
Anatomy clinical correlates: Female pelvis and perineum
Chlamydia trachomatis
Neisseria gonorrhoeae
Streptococcus agalactiae (Group B Strep)
Treponema pallidum (Syphilis)
Toxoplasma gondii (Toxoplasmosis)
Cytomegalovirus
Hepatitis B and Hepatitis D virus
Herpes simplex virus
HIV (AIDS)
Influenza virus
Parvovirus B19
Rubella virus
Varicella zoster virus
Congenital TORCH infections: Pathology review
Complications during pregnancy: Pathology review
Estrogens and antiestrogens
Progestins and antiprogestins
Uterine stimulants and relaxants

Decision-Making Tree

Transcript

Watch video only

Intrahepatic cholestasis of pregnancy, or ICP, is a rare pregnancy-specific liver disease that is characterized by pruritus and elevated serum bile acid levels. Typically, it presents in the third trimester with itching on the palms of the hands and soles of the feet, without a rash. It is a relatively uncommon disease but is associated with poor fetal outcomes, including preterm delivery, meconium-stained amniotic fluid, and stillbirth, due to an accumulation of bile acids in the fetus, as well as the amniotic fluid.

Let’s talk about the first steps to assessing a patient… When assessing patients who present with a chief concern suggesting ICP, start with a focused history and physical exam as well as labs, including total bile acids and liver transaminases, such as ALT and AST.

The hallmark symptom of ICP is pruritus, most often on the palms of the hands and soles of the feet which is worse at night. In general, symptoms start in the third trimester with the majority of cases diagnosed after 30 weeks gestation.

Risk factors include a personal or family history of ICP or preexisting hepatobiliary diseases, such as hepatitis C, nonalcoholic cirrhosis, and nonalcoholic pancreatitis, as well as gallstones and cholecystitis. ICP is also associated with advanced maternal age, multiple gestations, and in vitro fertilization.

On physical exam, there should be no rash present. If you visualize a rash, consider an alternative diagnosis, such as a dermatoses of pregnancy like atopic eruption of pregnancy, polymorphic eruption of pregnancy, or pemphigoid gestationis. That being said, you may note excoriations, since the pruritus can be quite intense.

When it comes to labs, the key finding in ICP is total bile acids greater than 10. Your patient’s liver transaminases may also be elevated. If the total bile acids are greater than 10 along with pruritus of the palms and soles without a rash, you can make the diagnosis of ICP. Also be sure to rule out other conditions that are associated with pruritus without a rash, such as chronic renal failure, liver disease, drugs such as opioids, and multiple sclerosis.

Here are a few clinical pearls about bile acids! When possible, check total bile acids in a fasting state, as there might be a small difference in levels between fasting and random blood work. However, if this is not a possibility, random bile acids will do just fine, as the difference is usually clinically insignificant and not likely to change clinical management. Additionally, if your patient’s total bile acids are initially normal and symptoms persist, repeat testing as indicated. This is because itching can actually precede an elevation in bile acids by several weeks! Finally, total bile acid levels can be repeated after making the diagnosis, as an elevation >100 will change management! This is because the higher the bile acids, the greater the risk for fetal complications.

Before we move on, here are some high-yield facts! Patients with bile acids greater than 40 are at an increased risk of developing preeclampsia. Preeclampsia typically develops a few weeks after the diagnosis of ICP, so it's important to discuss signs and symptoms to look out for with your patient. Also, if your patient’s initial screening for HCV was negative but is diagnosed with ICP, you should screen them again after this diagnosis.

Sources

  1. "ACOG committee opinion no 828. Indications for outpatient antenatal fetal surveillance" Obstet Gynecol (2021)
  2. "Intrahepatic cholestasis of pregnancy" Am J Obstet Gynecol (2021)
  3. "Beckmann and Ling’s Obstetrics and Gynecology" Wolters Kluwer (2023)
  4. "Intrahepatic cholestasis of pregnancy" Obstet Gynecol (2014)